Highly Potent Parenterals


Format: External webinar | Document type: Webinar

Highly Potent Parenterals
The economics of outsourcing highly potent molecules has always required careful decisionmaking, but even more so with today’s pipeline that includes less “blockbuster” type drugs and more “niche” or targeted molecules.New approaches to production decisions are needed in order to balance revenue from smaller patient populations with the cost of complex manufacturing processes that must adhere to stringent safety and regulatory requirements.This complimentary webinar from Baxter BioPharma Solutions provides insight on:The market and the economic risksInfrastructure neededCompliance and experience – where is your company on the learning curve?

Related resources from Baxter BioPharma Solutions

Show more

Supplier info centre